Kavar Capital Partners Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$2M |
| 2 |
Goldman Sachs
GS
|
+$1.47M |
| 3 |
GSK
GSK
|
+$1.35M |
| 4 |
Johnson & Johnson
JNJ
|
+$608K |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$360K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNCE
Snyders-Lance, Inc.
LNCE
|
+$3.92M |
| 2 |
Brown-Forman Class B
BF.B
|
+$2.98M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.52M |
| 4 |
General Mills
GIS
|
+$227K |
| 5 |
Yum! Brands
YUM
|
+$225K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 21.13% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 15.91% |
| 4 | Communication Services | 8.72% |
| 5 | Industrials | 6.82% |
Similar funds
Kavar Capital Partners Group's Q1 2018 Portfolio in Review
As of Q1 2018, Kavar Capital Partners Group held 454 positions worth $192M, up 1.8% from $188M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Kavar Capital Partners Group deployed $10.5M of net new capital in Q1 2018, opening 344 new positions and adding to 40 existing holdings. Its largest new stake was Gilead Sciences: 25,100 shares worth $1.89M.
By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $1.52M trimmed.
- Kavar Capital Partners Group's largest Q1 2018 buy was Gilead Sciences: 25,100 shares worth $1.89M.
- Kavar Capital Partners Group added most to GSK in Q1 2018, an estimated $1.35M increase.
- Kavar Capital Partners Group's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $1.52M.
- Kavar Capital Partners Group fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $3.92M.
- Kavar Capital Partners Group's ten largest holdings make up 24% of its $192M portfolio in Q1 2018.
- Kavar Capital Partners Group opened 344 new positions and closed 4 in Q1 2018.
- Kavar Capital Partners Group's portfolio value rose 1.8% quarter-over-quarter to $192M.
Based on Kavar Capital Partners Group's 13F filing for Q1 2018, filed 16 May 2019.